XVIVO PERFUSION AB XVIVO PERFUS - stock earnings
0RKL.L Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | 2.3 million SEK | 146.6 million SEK |
| 2023Q2 | 6.9 million SEK | 154.6 million SEK |
| 2023Q1 | 14.2 million SEK | 140.6 million SEK |
| 2022Q4 | 734000 SEK | 131.5 million SEK |
| 2021Q4 | 12.2 million SEK | 85.9 million SEK |
| 2021Q3 | -1.1 million SEK | 54.9 million SEK |
| 2021Q2 | -8.9 million SEK | 59.3 million SEK |
| 2021Q1 | 6.0 million SEK | 58.3 million SEK |
| 2020Q4 | -19.6 million SEK | 60.3 million SEK |
0RKL.L Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 18.4 million SEK | 415.3 million SEK |
| 2021 | 8.2 million SEK | 258.4 million SEK |
| 2020 | -43.7 million SEK | 179.9 million SEK |
| 2019 | 4.9 million SEK | 220.8 million SEK |
| 2018 | 12.7 million SEK | 187.9 million SEK |
| 2017 | 6.3 million SEK | 148.3 million SEK |
0RKL.L
Price: SEK403
52 week price:
Earnings Per Share: 0.24 SEK
P/E Ratio: 1168.70
Exchange: LSE
Sector: Healthcare
Industry: Health Care Equipment & Services
Market Capitalization: 102.7 million